Galecto, Inc.

Galecto, Inc.verified

GLTO

Price:

$24.38

Market Cap:

$38.94M

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is based in ...[Read more]

Industry

Biotechnology

IPO Date

2020-10-29

Stock Exchange

NASDAQ

Ticker

GLTO

The Enterprise Value as of April 2026 (TTM) for Galecto, Inc. (GLTO) is -217272338.00

According to Galecto, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -217272338.00. This represents a change of 271.23% compared to the average of -58527729.72 of the last 4 quarters.

Galecto, Inc. (GLTO) Historical Enterprise Value (quarterly & annually)

How has GLTO Enterprise Value performed in the past?

The mean historical Enterprise Value of Galecto, Inc. over the last ten years is 84.14M. The current -217272338.00 Enterprise Value has changed -25922.02% with respect to the historical average. Over the past ten years (40 quarters), GLTO's Enterprise Value was at its highest in in the March 2019 quarter at 378.94M. The Enterprise Value was at its lowest in in the December 2025 quarter at -219460643.79.

Quarterly (TTM)
Annual

Average

84.14M

Median

6.37M

Minimum

-202555680.00

Maximum

370.53M

Galecto, Inc. (GLTO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Galecto, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.22%

Maximum Annual Enterprise Value = 370.53M

Minimum Annual Increase = -118.62%

Minimum Annual Enterprise Value = -202555680.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-202555680.002.22%
2024-8721257.15318.42%
2023-2084322.00-24.52%
2022-2761535.00-118.62%
202114.83M-90.33%
2020153.36M-58.61%
2019370.53M5.70%

Galecto, Inc. (GLTO) Average Enterprise Value

How has GLTO Enterprise Value performed in the past?

The current Enterprise Value of Galecto, Inc. (GLTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-71120419.72

5-year avg

-40259092.88

10-year avg

84.14M

Galecto, Inc. (GLTO) Enterprise Value vs. Peers

How is GLTO’s Enterprise Value compared to its peers?

Galecto, Inc.’s Enterprise Value is greater than TransCode Therapeutics, Inc. (-17805845978.00), less than Phio Pharmaceuticals Corp. (-6974127.00), less than Aprea Therapeutics, Inc. (-9342031.00), less than Kiora Pharmaceuticals, Inc. (867.97K), less than IN8bio, Inc. (-17449757.00), greater than Acurx Pharmaceuticals, Inc. (-7552977593.00), less than Aptevo Therapeutics Inc. (588.96K), less than Lyra Therapeutics, Inc. (15.15M), less than Adial Pharmaceuticals, Inc. (-4398567.00), less than BioCardia, Inc. (4.70M),

Build a custom stock screener for Galecto, Inc. (GLTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galecto, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galecto, Inc. (GLTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galecto, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Galecto, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Galecto, Inc. (GLTO)?

What is the 3-year average Enterprise Value for Galecto, Inc. (GLTO)?

What is the 5-year average Enterprise Value for Galecto, Inc. (GLTO)?

How does the current Enterprise Value for Galecto, Inc. (GLTO) compare to its historical average?